相关实验视频
Updated: Jul 7, 2026
06:30
Intraductal Delivery to the Rabbit Mammary Gland
Published on: March 9, 2017
9.7K
针对侵袭性叶叶癌的地方区域考虑
Rita A Mukhtar1,2, Meghan R Flanagan3
1Division of Surgical Oncology, University of California, San Francisco, CA USA.
Current breast cancer reports
|December 30, 2025
概括
侵袭性叶状癌 (ILC) 的局部管理是可行的,乳腺保护疗法,瘤外科手术和新辅助化疗. 进一步的ILC特定研究对于解决管理这种常见乳腺癌亚型的知识差距至关重要.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- 侵袭性叶状腺癌 (ILC) 是第二种最常见的侵袭性乳腺癌类型,在地方区域的管理中提出了独特的挑战.
- 目前的文献综述侧重于优化ILC患者的手术和全身治疗方法.
研究的目的:
- 总结最近在侵袭性叶膜癌的局部区域管理方面的进展.
- 审查乳腺外科手术,关分期和ILC的新辅助疗法的现有证据.
主要方法:
- 对最近关于ILC管理的研究进行系统的文献审查.
- 对乳腺保存,边缘状况,手术和新辅助治疗疗效的数据进行分析.
主要成果:
- 乳腺保护疗法对ILC是安全的,尽管高的阳性边缘率可以通过剃须边缘和瘤塑料技术来减轻.
- 在ILC中缓解关手术的证据不足;通常建议使用哨兵淋巴结活检.
- 新辅助化疗显示出改善乳腺保护和增加结节完全反应的潜力,在选择的ILC患者中.
结论:
- 由于其独特的生物和临床特征,ILC的区域管理需要量身定制的方法.
- 进一步的ILC特定研究对于完善治疗指南和解决现有的知识差距至关重要.
更多相关视频
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.8K
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
753
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...